Division of Hospital Medicine, Department of Medicine, Northwell Health, Manhasset, NY, 11030, USA.
Division of Hospital Medicine, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, Manhasset, NY, 11030, USA.
J Thromb Thrombolysis. 2018 Apr;45(3):369-376. doi: 10.1007/s11239-018-1611-8.
Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States. Hospitalized, medically ill older adults have increased risk; despite guidelines, data suggest suboptimal pharmacologic prophylaxis rates. Factors influencing provider prescribing non-compliance are unclear. We aimed to describe VTE prophylaxis practices and identify risk factors for, and outcomes of, prescribing non-compliance. A retrospective study was conducted of hospitalized adults aged ≥ 75 years, admitted to the medicine service of a large academic tertiary center from May 1, 2014 to June 30, 2015. The primary outcome was non-compliance, defined as the absence of an order for VTE prophylaxis for the duration of hospitalization or an interruption of prophylaxis exceeding 24 h. Secondary measures included in-hospital mortality, length of stay (LOS), and 30-day readmissions. Of 3751 patients (mean age 84.7 years), 97.6% of charts had prophylaxis orders; 11.0% showed non-compliance. Pharmacologic prophylaxis was prescribed in 83.3% of patients and mechanical prophylaxis alone in 14.3%. Factors associated with non-compliance included: higher body mass index (BMI) (p = 0.04), myocardial infarction (p = 0.01), congestive heart failure (p = 0.001), metastatic tumor (p = 0.01). Low mobility was not significantly associated with compliance. Subcutaneous unfractionated heparin was associated with compliance (p < 0.0001); warfarin (p < 0.0001), heparin infusion (p < 0.0001) and low-molecular-weight heparin (p < 0.0001) with non-compliance. Non-compliance was associated with increased mortality (p = 0.01), LOS (p < 0.0001), readmissions (p = 0.0004). Known VTE risk factors (mobility, BMI, comorbidities) were not associated with prescriber compliance patterns. Integrating risk assessment models into provider practice may improve compliance.
静脉血栓栓塞症(VTE)是美国发病率和死亡率的主要原因。住院和患有内科疾病的老年人风险增加;尽管有指南,但数据表明药物预防率不理想。影响提供者处方不遵守的因素尚不清楚。我们旨在描述 VTE 预防措施,并确定处方不遵守的风险因素以及结果。对 2014 年 5 月 1 日至 2015 年 6 月 30 日期间在一家大型学术三级中心内科病房住院的年龄≥75 岁的成年人进行了回顾性研究。主要结果是不遵守,定义为在住院期间没有开具 VTE 预防药物或预防措施中断超过 24 小时。次要措施包括院内死亡率、住院时间(LOS)和 30 天再入院。在 3751 名患者中(平均年龄 84.7 岁),97.6%的病历中有预防措施医嘱;11.0%的患者不遵守。83.3%的患者开具了药物预防措施,14.3%的患者仅开具了机械预防措施。与不遵守相关的因素包括:更高的体重指数(BMI)(p=0.04)、心肌梗死(p=0.01)、充血性心力衰竭(p=0.001)、转移性肿瘤(p=0.01)。低活动度与合规性无显著相关性。皮下未分级肝素与合规性相关(p<0.0001);华法林(p<0.0001)、肝素输注(p<0.0001)和低分子肝素(p<0.0001)与不遵守相关。不遵守与死亡率增加(p=0.01)、住院时间延长(p<0.0001)和再入院相关(p=0.0004)。已知的 VTE 风险因素(活动度、BMI、合并症)与处方者的依从模式无关。将风险评估模型纳入提供者的实践中可能会提高依从性。